NCT01667809

Brief Summary

Background: Common mental illness, such as anxiety disorders and depression, is the main cause for sick leave in Sweden. Cognitive behavior therapy (CBT) has been shown to be effective in alleviating target symptoms of these disorders, but its effect on sick leave rates has not been sufficiently addressed. The investigators have developed an intervention called return to work (RTW), which is based in cognitive behavioral theory, that has a primary aim of helping sick-listed patients with common mental illness return to work. This new treatment has not been evaluated in a randomized controlled trial. Aims: The aim of this study is to investigate the effect of CBT and RTW for subclinical common mental illness in a randomized controlled trial conducted in primary care. Participants will be randomized to diagnosis specific CBT (n=50), RTW (n=50. Main outcomes are days of sick leave and clinician severity rating of psychiatric symptoms. This study could contribute to new knowledge regarding how to best treat patients on sick leave with mild common mental illness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Aug 2012

Typical duration for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2012

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

August 10, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 17, 2012

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

March 3, 2016

Status Verified

March 1, 2016

Enrollment Period

3.3 years

First QC Date

August 10, 2012

Last Update Submit

March 2, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Sick leave

    Number of days on sick leave

    1 year

  • Clinician Severity Rating (CSR)

    Change in CSR at post-treatment, 26 week follow-up, and 52 week follow-up compared to baseline.

    Baseine, post-treatment (12 weeks on average), 26 week follow-up, 52 week follow-up

Secondary Outcomes (14)

  • Montgomery-Ã…sberg Depression Rating Scale-Self-report (MADRS-S)

    Baseline, post-treatment (12 weeks on average), 26 week follow-up, 52 week follow-up

  • Insomnia Severity Index (ISI)

    Baseline, post-treatment (12 weeks on average) 26 week follow-up, 52 week follow-up

  • Health Anxiety Inventory (HAI)

    Baseline, post-treatment (12 weeks on average), 26 week follow-up, 52 week follow-up

  • Perceived Stress Scale (PSS)

    Baseline, post-treatment (12 weeks on average), 26 week follow-up, 52 week follow-up

  • Trimbos and Institute of Technology Cost Questionnaire for Psychiatry (TIC-P)

    Baseline, post-treatment (12 weeks on average), 26 week follow-up, 52 week follow-up

  • +9 more secondary outcomes

Study Arms (2)

Cognitive Behavior Therapy

ACTIVE COMPARATOR

As the trial will include several different common subclinical mental disorders, the cognitive behavior therapy used in the study will be based on the protocols with best empirical support. Cognitive behavior therapy entails psychoeducational components, i.e. the patient is learns about the disorder and how to view it from a cognitive behavioral perspective. The most important part of the treatment is systematic behavior changes often targeted at exposure to feared stimuli. This is combined with cognitive interventions targeted at challenging negative automatic thoughts. All treatments will be delivered by licensed psychologists.

Behavioral: Cognitive behavior therapy

Return to work

EXPERIMENTAL

Participants randomized to this arm will receive an experimental treatment, based in cognitive behavioral therapy, with primary aim to help patients return to work. Interventions are aimed at solving work-related problems and comprises problem-solving training and systematic employer-patient meetings aimed at facilitating a gradual return to the workplace. Licensed psychologists deliver all treatments.

Behavioral: Return to work

Interventions

Cognitive behavior therapy entails psychoeducational components, i.e. the patient is learns about the disorder and how to view it from a cognitive behavioral perspective. The most important part of the treatment is systematic behavior changes often targeted at exposure to feared stimuli. This is combined with cognitive interventions targeted at challenging negative automatic thoughts. All treatments will be delivered by licensed psychologists.

Cognitive Behavior Therapy
Return to workBEHAVIORAL

Participants randomized to this arm will receive an experimental treatment, based in cognitive behavioral therapy, with primary aim to help patients return to work. Interventions are aimed at solving work-related problems and comprises problem-solving training and systematic employer-patient meetings aimed at facilitating a gradual return to the workplace. Licensed psychologists deliver all treatments.

Return to work

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have been on sick leave (at least 50%) for at least 1 month and not more than 6 months
  • Have subclinical levels of anxiety disorder diagnosis (obsessive compulsive disorder, social phobia, panic disorder, generalized anxiety disorder, post-traumatic stress disorder, specific phobia), or/and major depression, or/and maladaptive stress reaction, or/and primary insomnia. Severity measured by clinical severity rating (CSR) 2-3 for mild subclinical level

You may not qualify if:

  • A higer score than 3 on the Clinician severity rating scale
  • A lower score than 2 on the Clinician severity rating scale

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Karolinska Institutet and Gustavsberg primary care center

Stockholm, Stockholm County, 13440, Sweden

Location

MeSH Terms

Conditions

Anxiety DisordersDepressive Disorder, MajorStress Disorders, TraumaticSleep Initiation and Maintenance Disorders

Interventions

Cognitive Behavioral TherapyReturn to Work

Condition Hierarchy (Ancestors)

Mental DisordersDepressive DisorderMood DisordersTrauma and Stressor Related DisordersSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Intervention Hierarchy (Ancestors)

Behavior TherapyPsychotherapyBehavioral Disciplines and ActivitiesEmploymentSocioeconomic FactorsPopulation Characteristics

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 10, 2012

First Posted

August 17, 2012

Study Start

August 1, 2012

Primary Completion

December 1, 2015

Study Completion

December 1, 2015

Last Updated

March 3, 2016

Record last verified: 2016-03

Locations